Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains

Abdallah K Al-Hakim1, Anna Zagorska, Louise Chapman

  • 1MRC Protein Phosphorylation Unit, MSI/WTB Complex, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland, UK.

The Biochemical Journal
|February 8, 2008
PubMed

Insights

AMPK-related kinases NUAK1 and MARK4 are regulated by the deubiquitinating enzyme USP9X. This study reveals unusual Lys(29)/Lys(33)-linked polyubiquitin chains control these key cell signaling proteins.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • AMPK-related kinases, including NUAK1 and MARK4, are crucial regulators of cell polarity and proliferation.
  • These kinases are activated by the LKB1 tumor suppressor kinase.
  • The precise regulatory mechanisms, particularly post-translational modifications, are not fully understood.

Purpose of the Study:

  • To investigate the role of ubiquitination and deubiquitination in the regulation of NUAK1 and MARK4.
  • To identify the specific ubiquitin linkages involved in the regulation of these kinases.
  • To explore the functional consequences of ubiquitination on NUAK1 and MARK4 activity.

Main Methods:

  • In vivo polyubiquitination assays.
  • Co-immunoprecipitation to study protein interactions.
  • Knockdown and overexpression studies of USP9X.
  • Analysis of ubiquitin chain topology (Lys(29)/Lys(33) linkages).
  • Site-directed mutagenesis to identify non-binding mutants.

Main Results:

  • NUAK1 and MARK4 were found to be polyubiquitinated in vivo and interact with USP9X.
  • USP9X deubiquitinates NUAK1 and MARK4, with knockdown of USP9X increasing their polyubiquitination.
  • Ubiquitin chains linked by Lys(29) and/or Lys(33) were identified on NUAK1 and MARK4.
  • Non-USP9X-binding mutants exhibited hyper-ubiquitination and reduced LKB1-mediated phosphorylation.
  • AMPK and other AMPK-related kinases also showed polyubiquitination.

Conclusions:

  • NUAK1 and MARK4 are substrates of the deubiquitinating enzyme USP9X.
  • The study provides the first evidence for regulation of AMPK family kinases by Lys(29)/Lys(33)-linked polyubiquitin chains.
  • Polyubiquitination, mediated by these unusual linkages, may serve as an inhibitory mechanism for NUAK1 and MARK4 activity.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...